Pricing Log in Create free account

Abbott Laboratories (ABT) vs DexCom, Inc. (DXCM)

Abbott Laboratories and DexCom, Inc. are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $196.6B against $31.5B — 6.2× the size. DexCom, Inc. trades at the lower P/E: 32.6× against 42.3×. DexCom, Inc. grew revenue faster over the last twelve months: 13.0% against 10.0%. DexCom, Inc. has the higher net margin (19.4% vs 9.75%) and the higher return on invested capital (39.0% vs 0.00%). Across the 22 metrics below, DexCom, Inc. leads on 16 and Abbott Laboratories on 6.

Valuation

Metric ABT DXCM Medical Devices median
P/E 42.32 32.61 25.58
P/S 4.09 6.20 2.54
P/B 3.81 12.48 2.48
Price to free cash flow 25.23 28.81 28.81
EV/EBITDA 20.79 21.24 11.51
EV/Sales 4.65 6.24 2.72
Earnings yield 2.36% 3.07% (12.82%)
Free cash flow yield 3.96% 3.47% (8.18%)

Profitability

Metric ABT DXCM Medical Devices median
Gross margin 56.94% 63.42% 57.76%
Operating margin 13.78% 23.98% (15.07%)
Net margin 9.75% 19.41% (14.45%)
Free cash flow margin 0.00% 21.52% (3.88%)
Return on equity 0.00% 37.67% (10.35%)
Return on assets 0.00% 14.43% (17.26%)
Return on invested capital 0.00% 39.00% (5.27%)

Growth

Metric ABT DXCM Medical Devices median
Revenue growth (TTM) 10.00% 13.03% 10.41%
EPS growth (last fiscal year) (51.31%) 47.18% 28.17%
Revenue growth, 5-year CAGR 5.08% 19.33% 15.74%
Net income growth, 5-year CAGR 7.74% 8.75% 0.00%

Health

Metric ABT DXCM Medical Devices median
Debt to equity 0.63 0.49 0.04
Current ratio 1.38 1.74 2.74
Net debt to EBITDA 0.36 (0.65) 0.54

Dividend

Metric ABT DXCM Medical Devices median
Dividend yield 2.22% — 1.02%
Payout ratio 0.94 — 0.37

Size

Metric ABT DXCM Medical Devices median
Market cap 196.57b 31.50b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack